Issue 132 • July 2023

AI for patients: Hype or Hope

While recent advancements see companies highlighting AI’s ability to empower patients, there is reluctance to fully embrace it

Briefing

Intercept winds down NASH programme after FDA pulls plug on Ocaliva

Interview

How Big Pharma implements analytics in continuous manufacturing

In Depth

Inflation reduction act boosts biologic VC financing over small molecules

In Data

Leading innovators in aircraft air conditioning

Thematic Take

Metaverse in Pharma